Phone-based support for preventing relapse in anorexia nervosa after hospitalization
Efficacy of a Phone-based Relapse Prevention for Anorexia Nervosa After a First Hospitalization
This study tests if regular phone support can help people with anorexia nervosa stay healthy after leaving the hospital, compared to just regular medical check-ins.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 270 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 6 sites (Hénin-Beaumont and 5 other locations) |
| Trial ID | NCT04102475 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a phone-based relapse prevention intervention for patients with anorexia nervosa (AN) following their first hospitalization. It compares the outcomes of patients receiving regular phone contact to those receiving standard medical follow-up. The primary goal is to assess changes in body weight at 12 months, while secondary objectives include evaluating changes in psychopathology and the economic impact of the intervention. The study is a multicenter, open-label, randomized controlled trial involving participants over the age of 15 diagnosed with AN.
Who should consider this trial
Good fit: Ideal candidates are individuals over 15 years old who have been hospitalized for anorexia nervosa and can provide informed consent.
Not a fit: Patients with severe psychiatric conditions, those unable to consent, or individuals who are homeless may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce relapse rates and improve long-term outcomes for patients recovering from anorexia nervosa.
How similar studies have performed: While phone contact has shown promise in other disorders, this specific approach for anorexia nervosa is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject over 15 years of age * Diagnosis of AN (restrictive and/or purgative) according to DSM-5 criteria * Included after a first inpatient hospitalization in specialized care * Providing informed, dated and signed consent (for a minor, consent must be signed by both parents who have parental authority ) * With medical insurance * Can be reached by telephone Exclusion Criteria: * Uncompensated psychiatric pathology * Refusal to participate in the study * The inability to consent to care (patient or his/her legal representative) * Pregnancy * Major incapable subject or under guardianship or judicial protection * Homelessness * No mastery of reading and writing
Where this trial is running
Hénin-Beaumont and 5 other locations
- Centre Hospitalier Général — Hénin-Beaumont, France (Not_yet_recruiting)
- Hôpital Fontan2, CHU — Lille, France (Recruiting)
- Hôpital Saint Vincent de Paul, GHICL — Lille, France (Not_yet_recruiting)
- Cliniqie Lautreamont — Loos, France (Not_yet_recruiting)
- CHU de Montpellier — Montpellier, France (Not_yet_recruiting)
- Centre Hospitalier Universitaire — Nantes, France (Not_yet_recruiting)
Study contacts
- Principal investigator: Olivier Cottencin, MD,PhD — University Hospital, Lille
- Study coordinator: Olivier Cottencin, MD,PhD
- Email: olivier.cottencin@chru-lille.fr
- Phone: 3 20 44 58 38
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.